Learn more about Abbott's line of Freestyle Libre continuous glucose monitors (CGMs).
Medtronic
+3
/
Aug 11, 2025
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
News
+4
Jul 8, 2025
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out.
Jun 20, 2025
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
CGM
+7
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Apr 21, 2025
Abbott's new app brings much needed upgrades like silence Low Alarms and control of all sensors under one umbrella.
